IGUCHI Taro

FacultyDepartment of Urology
PositionAssociate Professor

Research Activities

Published Papers

  • The Efficacy of Choreitogoshimotsuto for Radiation Hemorrhagic Cystitis, (Satoshi Tamada), Minoru Kato, Takeshi Yamasaki, Sayaka Yasuda, Taro Iguchi, Kampo Med73:187-1892022
  • The impact of enzalutamide on quality of life in men with metastatic hormone-sensitive prostate cancer based on prior therapy, risk, and symptom subgroups., (Stenzl A), Szmulewitz RZ, Petrylak D, Holzbeierlein J, Villers A, Azad A, Alcaraz A, Alekseev B, Iguchi T, Shore ND, Gomez-Veiga F, Ivanescu C, Rosbrook B, Ramaswamy K, Ganguli A, Haas GP, Armstrong AJ82:1237-12472022
  • Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer., (Armstrong AJ), Azad AA, Iguchi T, Szmulewitz RZ, Petrylak DP, Holzbeierlein J, Villers A, Alcaraz A, Alekseev B, Shore ND, Gomez-Veiga F, Rosbrook B, Zohren F, Yamada S, Haas GP, Stenzl A40:1616-16222022
  • Descriptive study on burden and communication of fatigue among castration-resistant prostate cancer patients in Japan., Iguchi T, Nakamura Y, Akiyama T, Chand K, Yu E28:417-4262022
  • Kamikihito Improves Cancer-related Fatigue in Castration-resistant Prostate Cancer Patients Receiving Enzalutamide: Multidimensional Approach Including metabolomics analysis., (Satoshi Tamada) , Taro Iguchi, Minoru Kato, Takeshi Yamasaki, Naoko Tsuchiya, Katuya Ohbuchi , Chika Shimbori, Junzo Nojima, Sayaka Yasuda, Kyoko Ebisu and Yasuyoshi Watanabe, Traditional & Kampo Medicine8:204-2102021
  • Descriptive study on burden and communication of fatigue among castration-resistant prostate cancer patients in Japan., Taro Iguchi, Yusuke Nakamura, Takeshi Akiyama, Krishant Chand and Eric Yu, Current Medical Research and Opinion10:1-10Dec. 2021
  • Editorial Comment to Non-metastatic Castration-resistant Prostate Cancer Treated with Salvage Focal Brachytherapy After External beam Radiotherapy., (Yukiyoshi Hirayama) and Taro Iguchi, IJU Case Reports4:230-2312021
  • The Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Oligometastatic Hormone-sensitive Prostate Cancer:A Post Hoc Analysis of ARCHES., (Andrew J. Armstrong), Taro Iguchi, Arun A. Azad, Arnauld Villers, Boris Alekseev, Daniel P. Petrylak, Russell Z. Szmulewitz, Antonio Alcaraz, Neal D. Shore, Jeffrey Holzbeierlein, Francisco Gomez-Veiga, Brad Rosbrook, Fabian Zohren, Gabriel P. Haas, Georgia Gourgiotti, Nader El-Chaar, Arnulf Stenzl, European Urology84:229-241Apr. 2023